Literature DB >> 211189

Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody.

J C Glorioso, L A Wilson, T W Fenger, J W Smith.   

Abstract

Surface antigens of BHK-21 cells infected with HSV-1 or HSV-2 were radioiodinated (125I) with lactoperoxidase, immune precipitated and analysed by polyacrylamide gel electrophoresis (PAGE). Experiments using antiserum to HSV-1 or HSV-2, absorbed with appropriate hemotypic or heterotypic antigens, revealed that both type-specific (homotypic) and cross-reactive antibody combined with surface glycoproteins to form a single large radioactive peak. This peak, which constituted the major glycoprotein region (region a) observed in electropherograms, represented a range in mol. wt. from 115000 to 130000. Sensitization of cells to complement lysis, neutralization of infectious virus and immune precipitation of surface glycoproteins (region a) were found to be generally correlated properties of all the antibody preparations analysed, including antibody prepared specifically against region a antigens. These findings suggest a major immunological role for the surface glycoproteins migrating in PAGE region a.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211189     DOI: 10.1099/0022-1317-40-2-443

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Herpes simplex virus glycoproteins: isolation of mutants resistant to immune cytolysis.

Authors:  N A Machtiger; B A Pancake; R Eberle; R J Courtney; S S Tevethia; P A Schaffer
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

2.  Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.

Authors:  S R Jennings; P A Lippe; K J Pauza; P G Spear; L Pereira; S S Tevethia
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

3.  Molecular genetics of herpes simplex virus. V. Characterization of a mutant defective in ability to form plaques at low temperatures and in a viral fraction which prevents accumulation of coreless capsids at nuclear pores late in infection.

Authors:  M Tognon; D Furlong; A J Conley; B Roizman
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

4.  Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.

Authors:  H J Zweerink; D Martinez; R J Lynch; L W Stanton
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.

Authors:  J C Glorioso; M Levine; T C Holland; M S Szczesiul
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

6.  Immune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections.

Authors:  H J Zweerink; L W Stanton
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Herpesvirus-induced "early" glycoprotein: characterization and possible role in immune cytolysis.

Authors:  V Misra; J E Gilchrist; G Weinmaster; L Qualtiere; S Van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

8.  Persistence of herpes simplex virus genes in cells of neuronal origin.

Authors:  M Levine; A L Goldin; J C Glorioso
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

9.  Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.

Authors:  H J Zweerink; L Corey
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.

Authors:  V C Carter; P L Rice; S S Tevethia
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.